Sotera Health (NASDAQ:SHC - Get Free Report) is expected to release its earnings data before the market opens on Thursday, February 27th. Analysts expect Sotera Health to post earnings of $0.21 per share and revenue of $291.37 million for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.
Sotera Health Price Performance
NASDAQ SHC remained flat at $13.52 on Friday. The company's stock had a trading volume of 864,109 shares, compared to its average volume of 869,181. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock's fifty day moving average is $13.45 and its two-hundred day moving average is $14.56. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock has a market capitalization of $3.83 billion, a P/E ratio of 54.08 and a beta of 1.91.
Analyst Upgrades and Downgrades
SHC has been the topic of several analyst reports. Royal Bank of Canada reissued an "outperform" rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. The Goldman Sachs Group initiated coverage on Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 target price on the stock. Barclays reduced their target price on Sotera Health from $18.00 to $17.00 and set an "overweight" rating on the stock in a report on Tuesday. Finally, Citigroup increased their target price on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $16.08.
Read Our Latest Analysis on Sotera Health
About Sotera Health
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
See Also
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
